TD Cowen raised the firm’s price target on Waters to $363 from $325 and keeps a Hold rating on the shares. The firm updated its model as management’s tone reflects Pharma spending is turning in particular.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT: